Who has invested in AbbVie?

Alcor Fund are named among the investors backing AbbVie.

AbbVie Funding: $15B Raised, Series D (2012)

AbbVie funding overview

AbbVie has raised $15B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is a Series D announced in November 2012. The round record for AbbVie runs through 2012; nothing later has been disclosed. Investors on record include Alcor Fund.

AbbVie at a glance

Total raised: $15B
Latest round: Series D
Latest round date: November 2012
Notable investors: Alcor Fund

Frequently asked about AbbVie funding

How much has AbbVie raised?: AbbVie has raised $15B in total disclosed funding across the rounds on record.
Who has invested in AbbVie?: Alcor Fund are named among the investors backing AbbVie.
What was the latest AbbVie funding round?: The most recent disclosed round is a Series D, announced in November 2012.
Where is AbbVie based?: No headquarters location is disclosed for AbbVie.
When did AbbVie last raise?: The last disclosed AbbVie round closed in November 2012 at Series D.

Totals shown for AbbVie aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.

AbbVie Funding: $15B Raised, Series D (2012)

AbbVie funding overview

AbbVie at a glance

Frequently asked about AbbVie funding

Companies related to AbbVie (30)

Browse related funding lists (3)